Literature DB >> 23290155

Pregnancy and delivery in cardiac disease.

Titia P E Ruys1, Jérôme Cornette, Jolien W Roos-Hesselink.   

Abstract

Although its prevalence is relatively low in pregnant women, heart disease is the most important cause of maternal mortality. Problems may arise due to hemodynamic burden and the hypercoagulable state of pregnancy. Heart disease may be congenital or acquired. In developed countries, the former composes the biggest part of women with heart disease. Patients with unrepaired lesions, cyanotic lesions, diminished systemic ventricular function, complex congenital heart disease, left ventricular outflow tract obstruction, pulmonary hypertension, or mechanical valves are at highest risk of developing complications during pregnancy. All patients with known cardiac disease should preferably be counseled before conception. Pre-pregnancy evaluation should include risk assessment for the mother and fetus, including medication use and information on heredity of the cardiac lesion. Management of pregnancy and delivery should be planned accordingly on individual bases. The types of complications are related to the cardiac diagnosis, with arrhythmias and heart failure being most common. Treatment options should be discussed with the future parents, as they may affect both mother and child. In general, the preferred route of delivery is vaginal. The optimal care for pregnant women with heart disease requires multidisciplinary involvement and is best concentrated in tertiary centers.
Copyright © 2012 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23290155     DOI: 10.1016/j.jjcc.2012.11.001

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  14 in total

Review 1.  Preconception Counseling for Women with Congenital Heart Disease.

Authors:  Chun-Wei Lu; Mei-Hwan Wu; Jou-Kou Wang; Min-Tai Lin; Chun-An Chen; Shenn-Nan Chiu; Hsin-Hui Chiu
Journal:  Acta Cardiol Sin       Date:  2015-11       Impact factor: 2.672

Review 2.  Hemodynamically Significant Congenital Cardiac Lesions in Pregnancy.

Authors:  Malavika Prabhu; Allison Bryant
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-05

3.  Management of an LCHADD Patient During Pregnancy and High Intensity Exercise.

Authors:  D C D van Eerd; I A Brussé; V F R Adriaens; R T Mankowski; S F E Praet; M Michels; M Langeveld
Journal:  JIMD Rep       Date:  2016-06-23

4.  Clinical features and peripartum outcomes in pregnant women with cardiac disease: a nationwide retrospective cohort study in Japan.

Authors:  Toshiaki Isogai; Hiroki Matsui; Hiroyuki Tanaka; Akira Kohyama; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Heart Vessels       Date:  2018-02-17       Impact factor: 2.037

5.  Pregnancy outcomes in patients with structural heart disease: a single center experience.

Authors:  Eun-Young Choi; Eun Sun Kim; Jung-Yoon Kim; Min-Kyung Song; Seong-Ho Kim; Chung Il Noh
Journal:  Cardiovasc Diagn Ther       Date:  2021-02

Review 6.  Pregnancy complicated by valvular heart disease: an update.

Authors:  Michael Nanna; Kathleen Stergiopoulos
Journal:  J Am Heart Assoc       Date:  2014-06-05       Impact factor: 5.501

7.  Prenatal and cardiovascular outcome in pregnant patients with dyspnea.

Authors:  Fateme Tara; Farveh Vakilian; Fateme Moosavi-Baigy; Maryam Salehi; Toktam Moghiman
Journal:  Res Cardiovasc Med       Date:  2015-03-23

Review 8.  Practical management of peripartum cardiomyopathy.

Authors:  Mi-Jeong Kim; Mi-Seung Shin
Journal:  Korean J Intern Med       Date:  2017-04-14       Impact factor: 2.884

Review 9.  Heart Disease and Pregnancy.

Authors:  Reza Ashrafi; Stephanie L Curtis
Journal:  Cardiol Ther       Date:  2017-07-05

10.  A clustering-based method for single-channel fetal heart rate monitoring.

Authors:  Encarnación Castillo; Diego P Morales; Antonio García; Luis Parrilla; Víctor U Ruiz; José A Álvarez-Bermejo
Journal:  PLoS One       Date:  2018-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.